Dataset Information


BCL6 is required for the initiation and maintenance of chronic myeloid leukemia

ABSTRACT: We identified the BCL6 protooncogene as a critical downstream effector of FoxO3A in self-renewal signaling of CML-initiating cells. BCL6 represses Arf and p53 in CML cells and is required for leukemia stem cell maintenance, colony formation and initiation of leukemia in transplant recipients. Importantly, peptide inhibition of BCL6 in human CML cells compromises colony formation and leukemia-initiation in xenotransplanted mouse recipients. These findings identify peptide-inhibition of BCL6 as a novel strategy to eradicate leukemia-initiating cells in CML. Overall design: Identification of BCL6 binding sites in human CML cell line JURL-MK1

INSTRUMENT(S): Illumina Genome Analyzer IIx (Homo sapiens)

ORGANISM(S): Homo sapiens  

SUBMITTER: Katerina Hatzi  

PROVIDER: GSE26085 | GEO | 2011-09-15



Similar Datasets

2011-09-15 | E-GEOD-26085 | ArrayExpress
| GSE85744 | GEO
2011-08-24 | GSE24813 | GEO
2011-08-23 | E-GEOD-24813 | ArrayExpress
2019-02-20 | BIOMD0000000733 | BioModels
2012-03-29 | E-GEOD-27060 | ArrayExpress
2011-02-15 | E-GEOD-24426 | ArrayExpress
2010-06-25 | BIOMD0000000662 | BioModels
2016-06-01 | E-GEOD-76123 | ArrayExpress
2011-05-17 | GSE29348 | GEO